pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3663 |
Genomic Coordinates | chr10: 117167678 - 117167774 |
Description | Homo sapiens miR-3663 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3663-5p | ||||||||||||||||||
Sequence | 21| GCUGGUCUGCGUGGUGCUCGG |41 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Northern | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | NAA50 | ||||||||||||||||||||
Synonyms | MAK3, NAT13, NAT13P, NAT5, NAT5P, SAN | ||||||||||||||||||||
Description | N(alpha)-acetyltransferase 50, NatE catalytic subunit | ||||||||||||||||||||
Transcript | NM_025146 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on NAA50 | |||||||||||||||||||||
3'UTR of NAA50 (miRNA target sites are highlighted) |
>NAA50|NM_025146|3'UTR 1 ACAAATTACAAATGAACTTTCTTGCACTTGCTTGTCGCCAAATAAAAGAGAGGCCCATTGATTCCTCCCCCACCCCAACA 81 CTTTTCTTTTAAAGCTTTTCTCCCTCCTTGTTCTTGTTTTTCTTTCTTCCTTTCCTTTTCTCTGAGAGTTTTAATACTTT 161 CAAGGACTTTAAAAAAATAATCATGTTTGAATTGTTTTCTCTTATTTTTGTGAGGTGGTTTGAAGGAAGGACAAGGTAGA 241 TCTGTTTAGTTTTGCAGTTGAAGTTAGATGGTCCTAAACATTTAATTGTCAAATAATTTCAAATTTAATGTCCTGCTTTC 321 ACATTGAAGGGCAGAGCCTACAAAACATTGTATATTTCAAAAGACAAAAAGAAGCAGCAGCAGTATCTTGTTCTCTAATT 401 CATAGACAAGTTGAGTGTGTTTGTGGTACTTTGGGTTTTTAAACACTTTGGGATACTAATCCCTAGACATTGCCTTCACT 481 CCACCTTTAGTCCTTCTGAGCACTCTCTCGGGAGTTGGAACATTGTTATCCTTGTAAGAAATACTAAGCTTATGTTGATT 561 TTTAAGTAATTATATCTTCTCTTCTTGCTGGTGGGTGGGGCAGTTTGGTTTAGTGTTATACTTTGGTCTAAGTATTTGAG 641 TTAAACTGCTTTTTTGCTAATGAGTGGGCTGGTTGTTAGCAGGTTTGTTTTTCCTGCTGTTGATTGTTACTAGTGGCATT 721 AACTTTTAGAATTTGGGCTGGTGAGATTAATTTTTTTTAATATCCCAGCTAGAGATATGGCCTTTAACTGACCTAAAGAG 801 GTGTGTTGTGATTTAATTTTTTCCCGTTCCTTTTTCTTCAGTAAACCCAACAATAGTCTAACCTTAAAAATTGAGTTGAT 881 GTCCTTATAGGTCACTACCCCTAAATAAACCTGAAGCAGGTGTTTTCTCTTGGACATACTAAAAAATACCTAAAAGGAAG 961 CTTAGATGGGCTGTGACACAAAAAATTCAATTACTGTCATCTAATGCCAGCTGTTAAAAGTGTGGCCACTGAGCATTTGA 1041 TTTTATAGGAAAAAATAGTATTTTTGAGAATAACATAGCTGTGCTATTGCACATCTGTTGGAGGACATCCCAGATTTGCT 1121 TATACTCAGTGCCTGTGATATTGAGTTTAAGGATTTGAGGCAGGGGTAATTATTAAACATATTGCTTCTATTCTTGGAAA 1201 AATAGAAGTGTAAAATGTTAATAATACAAATGTCACTGTGACCTCCTCCACTGAGAGGACTGGTTTATGCCAGATCATTT 1281 TCCGGCACACACGGAGTGGCTTTGACAGATTGATAACTTTGTAAGATGGGAGACATCTGAAATATTCATGTTTTCCTTTT 1361 GTAGTCCCATCTCCACTATTTAGAAATGTTCTCAGACTTTAAAATAATGCACAGGGCTTGAGCTTTCTGTCATTTGACTT 1441 TAAAAGGAAGTTTCATTCATATTTATCCTCTTATGTAAAATTGCGGTATAAAGTCTCATTTCCAAATATGTTAAATGACA 1521 AAATTATTTTATAAAATGTTTATGCACACTTTATAACCTTAAGTTTTTATTTGAGAATGTGAAAGTACAAAGTGCAGTAG 1601 ACTTCAACAATCTTGAGTGCCAAGAATAATACAGAAAAAGAAGACAGTTGATGAATGAGTTTATAGGGTTCTAATCTTAA 1681 GATGGTAAAAATGTAGAAAGACCTTGCTGGTTTTTTGGGGGTATTCGTTTCTTAAACAATCCAAATCTAAGCTTAGAAGA 1761 AAAGTTTAGCGTTAAGCACCTTTATCTTCATGAATAAGCTTCAGCTTGCTCTTGGCAAGAGAAGAGTGCTTGAGTTACAG 1841 AAGGCATAAGTAGTTTGAAGAATGCAGCAGCCTTTTTGTAAACTTCCCAGATATCAAAATAGACTTTGATATATAAATGG 1921 TTTTCTGAGATGACACTGCCTCTATTTCTATAACCATTTCACCTGGACTATCTAATCAGTCCTATGAATGTATCCCTAAA 2001 TGTGGTTATTGAAAACCTAATAGCTGCCTCATGACAAGTACATGTTATTTAAGGAGGAAAAAATATTAAATTTTGAATTG 2081 AGTGTGTAGGCTCCCTATCATTATATATAGAGTTTCTTTTTCCACGGTAGTCAGTGACTTAACCTGAATTGTAAATGTTT 2161 GTAAAGGGTTAATTGTCCTACATCAAACTTAGTTAAATAATTCCATCCACTTATGGAGGAGGAGGAGAATGTGGAAGAGG 2241 TAAAAAGCTGGGCACAAGTTCATATGCCTATGAGTCAGTAAAGACTGAAGTAATGTCCTATGTTGAGCTGGTTATTTTGA 2321 TATATGATAATAATTATCTTTGAAGTAGAACAATTCTGTTAACTGGAAAATCACAGGATATATCCATCATATTTTTCAGG 2401 ACAGATAGTTTTTACTGTGGGGCAAATAGGTTAAAATTACACTATGTTAGTTGCATTTAGGTTTTAAAGCAAAGAATCTG 2481 TAGAGAAATCTATGCAATATATAGTTTGTCCAGATTAGCTTTCATTTGGGGAATGAAGTTCTGAAATATCTAAAGCAGTT 2561 TACTCATCAATTGAAAAGTCCTCCAAAAAGAGAACTATTGGGAAACCATGGTGTGGTGGTGGAAAAGAAAAGCTCCCTCA 2641 GTTTTTTGGAGGGAATAACTTAAAAAAATACTTAAATGGCTAAGTTTACTTGGTGCAGTTAAGAATTAAACTTGTCAATT 2721 TTAACATTGCTGTTACATCTGAAATAAACTTATGTGATGTTCTGGTAGTGATCTGTGATATCTGTAAATGTCAAAACTGT 2801 ATTGTTGAATTCTGCAGCCAGCAACCGTACATACTCATTGTGTAGTGTTTCCCTTACTGCTTTTATTTACTTTCACATTT 2881 AAGATCTAATTTTAAAATCATTAAAATAGGCCAAGTGTAATTAAGGCATCCTAATTCAGATCTTCTGTGACTTGCTAGGT 2961 ACAGTGCCCAATATCTACAATTCAGTTCCAATGAGAGGGAAAAAGTAAGATCCAAGGAACTGTCTTGCTGCTGTATTTTT 3041 AATGTAATTATTAGAAATACTTGACACTTTAGGCTGCAATCTAGTTAGTAATGTTTATTGGCTACAGACAACATATTCAG 3121 GTGTTTTGTTTTTCTTCCTTGTAAGGAAGGAGTACGGTAGTTCAATGAGTTGGGAATTGGCTTTTAAGCTTTTTATCAAA 3201 CATGAATTTAAGATTTTTTCTTTAACAGAATTCAGTATTTAATATTTCTAGTCAAAATTGTTATAATTAGATTTTTGCTT 3281 TTTTCATTTAAGAAGCAATGAGTGATCCTTGTCTAGTGTGTCTCAGTTATTACTGTAGTTTAAAACAACAAACAAGTATT 3361 ACCTTCCACAGTTCTGGATCAGGAATCTAGGAGCTGCTTAACTGGGTGGTTCTGTCTTGAGATCTCAGAAGGTTGCAGTC 3441 AAGCTGTTAGCCAGGACTGTACCATCTTGAAGCTTGACAAGGCTAGAGGAGCCATTTCCAAGATGTCTTGCTTACGTGGC 3521 TCTTGGGCTTCTGTTCCTCACTGTGTGGGTATCACACACAGTGCCTGATGCTCACGTGGCTCTTGGGCTTCAGTTCCTTG 3601 GGCACCAGTTGCCTGGTGGACAACTGGTATGTGGCTTCCCCTAGAGCAGGTGATATAAGAAAGTGAGCAGAAACCATACT 3681 TTTTTATGACGTAGCCTCAGGTGACATTATTTCTGCCATATTCCATGAGTCACACAGACCAACCATTGAATCAGCTTGGT 3761 ATAGTGTGGGAGGGGACTGCACAAGGATGTGAATACTGGGAGGTGGATATCATTGGGCCCTCTAGGAGACTGGCTATCAC 3841 TGCTCAGAGAAGATGCTGGGCTTCGTTGACTCCCAAGGTCAGGGTAGTTTTGGTTAGGTTGTGTTTTATTAGTCTCTAAA 3921 AGGAGTAGTTTTCTAAATGAGGGTTATAAAGCACTGCACTTTACAGTTATTCGGGATATAAAAGAAATAGTGGGTCTAAA 4001 GGCTGTGCTCTTGTGGTTGGGTTTTCAGTGGGGAGGGGAGACTAGTCTGTCTCAGACTGATGCTGTTCTCACTGATTTGA 4081 ATATTTCTGGGAAATTGGATACTACAGTCACAAATAGGAACAGTAAGCCTATAGAAGTTTTTCAGGGAGTAAATATTTTC 4161 TATGGCAGTGTCCTGAATTGGTTCTCCCTTGCAAGACTGAACTGTAGGAACTTAGTCCTAGTTTATGATACAGCCAAGTA 4241 ACATAGTCACATGGGAAAAAGAGCTTGAGTCAGATTTCTTAATGTGTGTTGTTAACTTGGTAGAACATTGAGAATTATTT 4321 AAGTCAGAGAACGATCTGTTACTGGGGCAGAAATTCTCAACCTTTTCAGTTCTCCAAAATTTAAGATACTTGATTTCTTA 4401 GGTAAAATGTTTTTGTTTTTGTTTTGGAGACAGAGTCTCGCTCTGTCGCCCAGGCTGGAGTGCAGTGGCGCGATCTTGGC 4481 TCACTGCAAACTCCGCCTCCCAGATTCAAGCAATTCTGCCTGAGCCTCCCAAGTAGCTGCGACTAGAAAGCGCATGCCAC 4561 CACGCCTGGCTAATTTTTTGTATTTTAGTAGAGATGGGGGTTTCACCGTGTTGCCCAGGCTGGTCTCAAACTCCTGAGCT 4641 TAGGCAATCCTCCTGGGGCAGCCTCCCAAAGTGCTAGGATTACAGGCGAGCCATGGCGCCTGGCCAGTAAAATGTTTTCT 4721 ATCTAGAATGAATCAAGGTATTTTCCTTGCTCAGTAGCTTCTAGAATAAGAAAAAAATAGCAGCAAGATCTGATTCAGAA 4801 ATAGTTGGGAGCAGAAAGTTAATATGAAGGAGTTGCTACTTGTTAACAGCCTAGAGTTGAGATCTAGAAGAATTATTACC 4881 TTTTTAAATTTGTGATGAAAGCTTAAATCCAGCATTTGGGAAGTTACTCTATTGGCTGAACTATTTTGGAGTTTGTAAGC 4961 TTTGTATTAGATATTCCTGATTTAACTGAAACTAATTTGCCACATAGCTTTAATTTCATCCCAGTTTTACTTGTTTTACT 5041 GTCCTCAAAAACTCAAGACATCTGAACTCAAAGGATCTAAGCAGTATAAATTAAAGCACATGTTGAATCACTGTAGCTTT 5121 CGTAGGACATCTGATTATAATGCTTTTCTTTGTTTCTTTGTCCATACTGAACTTGTCTAGTTTATCTTTGAGAAACATTT 5201 GCTAGTATCAAAAATCTTCTGTAAAGATTTGAACAATCTTGAATTCTCCTTGTCACTAGCCATCTCTTCCCCTAAAGTAT 5281 AATAAAACTGTCAGGTACTAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | hESCs (WA-09) | ||||||
Disease | 80218.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 80218.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760639. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP-MDV_A
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000240922.3 | 3UTR | UGAGGUCGUGGGUUCGAGACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000240922.3 | 3UTR | CUGAGGUCGUGGGUUCGAGACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000240922.3 | 3UTR | GACCAGCUGACCAACAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1065668 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000240922.3 | 3UTR | CUGAGGUCGUGGGUUCGAGACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
203 hsa-miR-3663-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT222528 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT442432 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 6 | ||||||||
MIRT450423 | BCL2L14 | BCL2 like 14 | 2 | 2 | ||||||||
MIRT456341 | RCSD1 | RCSD domain containing 1 | 2 | 2 | ||||||||
MIRT479763 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT487162 | IFRD1 | interferon related developmental regulator 1 | 2 | 8 | ||||||||
MIRT495471 | ALDOA | aldolase, fructose-bisphosphate A | 2 | 2 | ||||||||
MIRT497193 | DUSP18 | dual specificity phosphatase 18 | 2 | 2 | ||||||||
MIRT499717 | PAGR1 | PAXIP1 associated glutamate rich protein 1 | 2 | 10 | ||||||||
MIRT502681 | CSNK1G3 | casein kinase 1 gamma 3 | 2 | 8 | ||||||||
MIRT503641 | POLR2F | RNA polymerase II subunit F | 2 | 4 | ||||||||
MIRT510824 | SBNO1 | strawberry notch homolog 1 | 2 | 4 | ||||||||
MIRT512347 | ZNF665 | zinc finger protein 665 | 2 | 4 | ||||||||
MIRT512528 | ATCAY | ATCAY, caytaxin | 2 | 4 | ||||||||
MIRT513246 | FBXO17 | F-box protein 17 | 2 | 4 | ||||||||
MIRT513502 | NAA50 | N(alpha)-acetyltransferase 50, NatE catalytic subunit | 2 | 6 | ||||||||
MIRT516033 | PTAFR | platelet activating factor receptor | 2 | 2 | ||||||||
MIRT517669 | TRIM72 | tripartite motif containing 72 | 2 | 2 | ||||||||
MIRT517691 | FAM175A | abraxas 1, BRCA1 A complex subunit | 2 | 2 | ||||||||
MIRT519524 | ZNF8 | zinc finger protein 8 | 2 | 2 | ||||||||
MIRT520953 | SRSF10 | serine and arginine rich splicing factor 10 | 2 | 2 | ||||||||
MIRT522074 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | 2 | 4 | ||||||||
MIRT525333 | CNGB1 | cyclic nucleotide gated channel beta 1 | 2 | 2 | ||||||||
MIRT526504 | POU5F1B | POU class 5 homeobox 1B | 2 | 2 | ||||||||
MIRT527847 | RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 2 | 2 | ||||||||
MIRT529211 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT530071 | VN1R1 | vomeronasal 1 receptor 1 | 2 | 2 | ||||||||
MIRT530639 | PPIC | peptidylprolyl isomerase C | 2 | 4 | ||||||||
MIRT530679 | CHRNB1 | cholinergic receptor nicotinic beta 1 subunit | 2 | 4 | ||||||||
MIRT532177 | SEC14L5 | SEC14 like lipid binding 5 | 2 | 2 | ||||||||
MIRT532432 | DHX33 | DEAH-box helicase 33 | 2 | 2 | ||||||||
MIRT532832 | ZNF704 | zinc finger protein 704 | 2 | 2 | ||||||||
MIRT534236 | SLC25A16 | solute carrier family 25 member 16 | 2 | 4 | ||||||||
MIRT535115 | PLXNA2 | plexin A2 | 2 | 2 | ||||||||
MIRT535563 | OMD | osteomodulin | 2 | 2 | ||||||||
MIRT536487 | KIAA1468 | KIAA1468 | 2 | 2 | ||||||||
MIRT538371 | CRISPLD2 | cysteine rich secretory protein LCCL domain containing 2 | 2 | 2 | ||||||||
MIRT539931 | NUCB1 | nucleobindin 1 | 2 | 4 | ||||||||
MIRT562305 | GINM1 | glycoprotein integral membrane 1 | 2 | 2 | ||||||||
MIRT563280 | BBS10 | Bardet-Biedl syndrome 10 | 2 | 2 | ||||||||
MIRT618205 | C22orf39 | chromosome 22 open reading frame 39 | 2 | 2 | ||||||||
MIRT620113 | HARBI1 | harbinger transposase derived 1 | 2 | 2 | ||||||||
MIRT621189 | FAM153B | family with sequence similarity 153 member B | 2 | 2 | ||||||||
MIRT623755 | GRID1 | glutamate ionotropic receptor delta type subunit 1 | 2 | 2 | ||||||||
MIRT624059 | EIF4E | eukaryotic translation initiation factor 4E | 2 | 2 | ||||||||
MIRT625016 | TMIGD2 | transmembrane and immunoglobulin domain containing 2 | 2 | 2 | ||||||||
MIRT626073 | CWF19L1 | CWF19 like 1, cell cycle control (S. pombe) | 2 | 2 | ||||||||
MIRT627875 | PAN2 | PAN2 poly(A) specific ribonuclease subunit | 2 | 2 | ||||||||
MIRT629306 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | 1 | 1 | ||||||||
MIRT630446 | IDE | insulin degrading enzyme | 2 | 2 | ||||||||
MIRT631000 | ZNF573 | zinc finger protein 573 | 2 | 2 | ||||||||
MIRT631093 | UQCRB | ubiquinol-cytochrome c reductase binding protein | 2 | 2 | ||||||||
MIRT631282 | SGSM1 | small G protein signaling modulator 1 | 2 | 2 | ||||||||
MIRT631530 | MYO6 | myosin VI | 2 | 2 | ||||||||
MIRT631642 | WDR91 | WD repeat domain 91 | 2 | 4 | ||||||||
MIRT631825 | TMEM154 | transmembrane protein 154 | 2 | 2 | ||||||||
MIRT632778 | LZIC | leucine zipper and CTNNBIP1 domain containing | 2 | 2 | ||||||||
MIRT633278 | FGFR1OP2 | FGFR1 oncogene partner 2 | 2 | 2 | ||||||||
MIRT633658 | SLC28A1 | solute carrier family 28 member 1 | 2 | 2 | ||||||||
MIRT634071 | PLIN3 | perilipin 3 | 2 | 2 | ||||||||
MIRT634159 | YME1L1 | YME1 like 1 ATPase | 2 | 2 | ||||||||
MIRT634227 | TMEM132B | transmembrane protein 132B | 2 | 2 | ||||||||
MIRT636401 | MYO5A | myosin VA | 2 | 2 | ||||||||
MIRT638678 | GCLM | glutamate-cysteine ligase modifier subunit | 2 | 2 | ||||||||
MIRT640231 | TOMM40 | translocase of outer mitochondrial membrane 40 | 2 | 2 | ||||||||
MIRT640304 | PRR13 | proline rich 13 | 2 | 2 | ||||||||
MIRT641125 | NPHP3 | nephrocystin 3 | 2 | 2 | ||||||||
MIRT643422 | ERVMER34-1 | endogenous retrovirus group MER34 member 1, envelope | 2 | 2 | ||||||||
MIRT643700 | KIAA0586 | KIAA0586 | 2 | 2 | ||||||||
MIRT644314 | NFKBID | NFKB inhibitor delta | 2 | 2 | ||||||||
MIRT644345 | MPV17L | MPV17 mitochondrial inner membrane protein like | 2 | 2 | ||||||||
MIRT645736 | POLR3A | RNA polymerase III subunit A | 2 | 2 | ||||||||
MIRT648058 | TRMT10C | tRNA methyltransferase 10C, mitochondrial RNase P subunit | 2 | 2 | ||||||||
MIRT649462 | UBA5 | ubiquitin like modifier activating enzyme 5 | 2 | 2 | ||||||||
MIRT650009 | KLB | klotho beta | 2 | 2 | ||||||||
MIRT650567 | YIPF4 | Yip1 domain family member 4 | 2 | 2 | ||||||||
MIRT652639 | TIMM10 | translocase of inner mitochondrial membrane 10 | 2 | 2 | ||||||||
MIRT653887 | SGK3 | serum/glucocorticoid regulated kinase family member 3 | 2 | 2 | ||||||||
MIRT655369 | PCBD2 | pterin-4 alpha-carbinolamine dehydratase 2 | 2 | 2 | ||||||||
MIRT659116 | DENND6A | DENN domain containing 6A | 2 | 2 | ||||||||
MIRT659520 | CHST3 | carbohydrate sulfotransferase 3 | 2 | 2 | ||||||||
MIRT659946 | C8orf44-SGK3 | C8orf44-SGK3 readthrough | 2 | 2 | ||||||||
MIRT661384 | RHCG | Rh family C glycoprotein | 2 | 2 | ||||||||
MIRT662910 | MED18 | mediator complex subunit 18 | 2 | 2 | ||||||||
MIRT663107 | NPR1 | natriuretic peptide receptor 1 | 2 | 2 | ||||||||
MIRT663759 | ZNF285 | zinc finger protein 285 | 2 | 2 | ||||||||
MIRT664554 | MKI67IP | nucleolar protein interacting with the FHA domain of MKI67 | 1 | 1 | ||||||||
MIRT664611 | LIMD1 | LIM domains containing 1 | 2 | 2 | ||||||||
MIRT666193 | SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 | 2 | 2 | ||||||||
MIRT666794 | PSMD1 | proteasome 26S subunit, non-ATPase 1 | 2 | 2 | ||||||||
MIRT668752 | DDX19B | DEAD-box helicase 19B | 2 | 2 | ||||||||
MIRT669601 | AGO3 | argonaute 3, RISC catalytic component | 2 | 2 | ||||||||
MIRT669704 | AAK1 | AP2 associated kinase 1 | 2 | 2 | ||||||||
MIRT669812 | STOML1 | stomatin like 1 | 2 | 2 | ||||||||
MIRT669927 | LRPAP1 | LDL receptor related protein associated protein 1 | 2 | 2 | ||||||||
MIRT669951 | FBXL2 | F-box and leucine rich repeat protein 2 | 2 | 2 | ||||||||
MIRT670005 | GPR156 | G protein-coupled receptor 156 | 2 | 4 | ||||||||
MIRT670051 | RPP14 | ribonuclease P/MRP subunit p14 | 2 | 2 | ||||||||
MIRT670301 | RBBP4 | RB binding protein 4, chromatin remodeling factor | 2 | 2 | ||||||||
MIRT670390 | EMP2 | epithelial membrane protein 2 | 2 | 2 | ||||||||
MIRT670457 | RSBN1L | round spermatid basic protein 1 like | 2 | 2 | ||||||||
MIRT670486 | DCUN1D2 | defective in cullin neddylation 1 domain containing 2 | 2 | 2 | ||||||||
MIRT670568 | GLTP | glycolipid transfer protein | 2 | 2 | ||||||||
MIRT671061 | KIF1B | kinesin family member 1B | 2 | 2 | ||||||||
MIRT671085 | ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | 2 | 2 | ||||||||
MIRT671306 | RABGAP1L | RAB GTPase activating protein 1 like | 2 | 2 | ||||||||
MIRT671807 | WISP3 | WNT1 inducible signaling pathway protein 3 | 2 | 2 | ||||||||
MIRT671956 | SPPL3 | signal peptide peptidase like 3 | 2 | 2 | ||||||||
MIRT671993 | OSTF1 | osteoclast stimulating factor 1 | 2 | 2 | ||||||||
MIRT672092 | WDR5B | WD repeat domain 5B | 2 | 2 | ||||||||
MIRT672273 | SHE | Src homology 2 domain containing E | 2 | 2 | ||||||||
MIRT672447 | TTPAL | alpha tocopherol transfer protein like | 2 | 2 | ||||||||
MIRT672451 | SLC4A1 | solute carrier family 4 member 1 (Diego blood group) | 2 | 2 | ||||||||
MIRT673652 | CYCS | cytochrome c, somatic | 2 | 2 | ||||||||
MIRT674003 | KCNN3 | potassium calcium-activated channel subfamily N member 3 | 2 | 2 | ||||||||
MIRT674054 | ATXN3 | ataxin 3 | 2 | 2 | ||||||||
MIRT674248 | NUP62 | nucleoporin 62 | 2 | 2 | ||||||||
MIRT674437 | MIOX | myo-inositol oxygenase | 2 | 4 | ||||||||
MIRT674476 | BCL2L15 | BCL2 like 15 | 2 | 2 | ||||||||
MIRT675472 | NUBPL | nucleotide binding protein like | 2 | 2 | ||||||||
MIRT675667 | IVD | isovaleryl-CoA dehydrogenase | 2 | 2 | ||||||||
MIRT675978 | FAM126B | family with sequence similarity 126 member B | 2 | 2 | ||||||||
MIRT676064 | HSPE1-MOB4 | HSPE1-MOB4 readthrough | 2 | 2 | ||||||||
MIRT676120 | SCIMP | SLP adaptor and CSK interacting membrane protein | 2 | 2 | ||||||||
MIRT676241 | PARP2 | poly(ADP-ribose) polymerase 2 | 2 | 2 | ||||||||
MIRT676257 | PBOV1 | prostate and breast cancer overexpressed 1 | 2 | 2 | ||||||||
MIRT676388 | SEC24D | SEC24 homolog D, COPII coat complex component | 2 | 2 | ||||||||
MIRT676744 | SGTB | small glutamine rich tetratricopeptide repeat containing beta | 2 | 2 | ||||||||
MIRT676880 | ENSA | endosulfine alpha | 2 | 2 | ||||||||
MIRT676905 | PHLDA3 | pleckstrin homology like domain family A member 3 | 2 | 2 | ||||||||
MIRT676922 | KLHDC8A | kelch domain containing 8A | 2 | 2 | ||||||||
MIRT676968 | RNF19B | ring finger protein 19B | 2 | 2 | ||||||||
MIRT677048 | ZNF34 | zinc finger protein 34 | 2 | 2 | ||||||||
MIRT677114 | SS18L1 | SS18L1, nBAF chromatin remodeling complex subunit | 2 | 2 | ||||||||
MIRT677324 | PIGO | phosphatidylinositol glycan anchor biosynthesis class O | 2 | 2 | ||||||||
MIRT677466 | PDLIM3 | PDZ and LIM domain 3 | 2 | 2 | ||||||||
MIRT677584 | TRIM65 | tripartite motif containing 65 | 2 | 2 | ||||||||
MIRT677646 | HAUS2 | HAUS augmin like complex subunit 2 | 2 | 2 | ||||||||
MIRT677736 | MOB4 | MOB family member 4, phocein | 2 | 2 | ||||||||
MIRT677813 | MRPS10 | mitochondrial ribosomal protein S10 | 2 | 2 | ||||||||
MIRT677830 | TSPYL1 | TSPY like 1 | 2 | 2 | ||||||||
MIRT678083 | EIF2A | eukaryotic translation initiation factor 2A | 2 | 2 | ||||||||
MIRT678158 | ZNF724P | zinc finger protein 724 | 2 | 2 | ||||||||
MIRT678256 | FXN | frataxin | 2 | 2 | ||||||||
MIRT678326 | FBLIM1 | filamin binding LIM protein 1 | 2 | 2 | ||||||||
MIRT678419 | ANKRD36 | ankyrin repeat domain 36 | 2 | 2 | ||||||||
MIRT678588 | C15orf40 | chromosome 15 open reading frame 40 | 2 | 2 | ||||||||
MIRT678598 | ARPC2 | actin related protein 2/3 complex subunit 2 | 2 | 2 | ||||||||
MIRT678831 | PDE6A | phosphodiesterase 6A | 2 | 2 | ||||||||
MIRT678945 | MYADM | myeloid associated differentiation marker | 2 | 2 | ||||||||
MIRT679046 | CHCHD5 | coiled-coil-helix-coiled-coil-helix domain containing 5 | 2 | 2 | ||||||||
MIRT679201 | FLVCR1 | feline leukemia virus subgroup C cellular receptor 1 | 2 | 2 | ||||||||
MIRT679205 | FAM9B | family with sequence similarity 9 member B | 2 | 2 | ||||||||
MIRT679223 | MAN2A2 | mannosidase alpha class 2A member 2 | 2 | 2 | ||||||||
MIRT679270 | POLM | DNA polymerase mu | 2 | 2 | ||||||||
MIRT679288 | DEGS1 | delta 4-desaturase, sphingolipid 1 | 2 | 2 | ||||||||
MIRT679316 | NPHP1 | nephrocystin 1 | 2 | 2 | ||||||||
MIRT679485 | CYTIP | cytohesin 1 interacting protein | 2 | 2 | ||||||||
MIRT679551 | LIPG | lipase G, endothelial type | 2 | 2 | ||||||||
MIRT679625 | TTC31 | tetratricopeptide repeat domain 31 | 2 | 2 | ||||||||
MIRT679649 | MMAB | methylmalonic aciduria (cobalamin deficiency) cblB type | 2 | 2 | ||||||||
MIRT679761 | TLR6 | toll like receptor 6 | 2 | 2 | ||||||||
MIRT680124 | ZNF576 | zinc finger protein 576 | 2 | 2 | ||||||||
MIRT680186 | ZNF554 | zinc finger protein 554 | 2 | 2 | ||||||||
MIRT684282 | CDK9 | cyclin dependent kinase 9 | 2 | 2 | ||||||||
MIRT689671 | RBM23 | RNA binding motif protein 23 | 2 | 2 | ||||||||
MIRT690031 | CCDC90B | coiled-coil domain containing 90B | 2 | 2 | ||||||||
MIRT691447 | CXorf36 | chromosome X open reading frame 36 | 2 | 2 | ||||||||
MIRT691547 | FLYWCH2 | FLYWCH family member 2 | 2 | 2 | ||||||||
MIRT691726 | LARS | leucyl-tRNA synthetase | 2 | 2 | ||||||||
MIRT692029 | ARSK | arylsulfatase family member K | 2 | 2 | ||||||||
MIRT692635 | SUSD1 | sushi domain containing 1 | 2 | 2 | ||||||||
MIRT693823 | BACE2 | beta-site APP-cleaving enzyme 2 | 2 | 2 | ||||||||
MIRT693864 | IYD | iodotyrosine deiodinase | 2 | 2 | ||||||||
MIRT693977 | ZNF70 | zinc finger protein 70 | 2 | 2 | ||||||||
MIRT694145 | CYP27C1 | cytochrome P450 family 27 subfamily C member 1 | 2 | 2 | ||||||||
MIRT695486 | TRAT1 | T-cell receptor associated transmembrane adaptor 1 | 2 | 2 | ||||||||
MIRT695544 | MAP4K2 | mitogen-activated protein kinase kinase kinase kinase 2 | 2 | 2 | ||||||||
MIRT695599 | TMEM199 | transmembrane protein 199 | 2 | 2 | ||||||||
MIRT696003 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | 2 | 2 | ||||||||
MIRT696020 | TYRO3 | TYRO3 protein tyrosine kinase | 2 | 2 | ||||||||
MIRT696039 | KCNK6 | potassium two pore domain channel subfamily K member 6 | 2 | 2 | ||||||||
MIRT696310 | NIP7 | NIP7, nucleolar pre-rRNA processing protein | 2 | 2 | ||||||||
MIRT696400 | CORO7 | coronin 7 | 2 | 2 | ||||||||
MIRT696595 | ORMDL2 | ORMDL sphingolipid biosynthesis regulator 2 | 2 | 2 | ||||||||
MIRT698044 | TRPM7 | transient receptor potential cation channel subfamily M member 7 | 2 | 2 | ||||||||
MIRT698139 | TNRC6B | trinucleotide repeat containing 6B | 2 | 2 | ||||||||
MIRT702561 | KBTBD6 | kelch repeat and BTB domain containing 6 | 2 | 2 | ||||||||
MIRT703018 | HEATR5A | HEAT repeat containing 5A | 2 | 2 | ||||||||
MIRT705118 | C4orf29 | abhydrolase domain containing 18 | 2 | 2 | ||||||||
MIRT706303 | NT5C2 | 5'-nucleotidase, cytosolic II | 2 | 2 | ||||||||
MIRT706610 | CYB5B | cytochrome b5 type B | 2 | 2 | ||||||||
MIRT706729 | RFK | riboflavin kinase | 2 | 2 | ||||||||
MIRT707321 | TMEM184B | transmembrane protein 184B | 2 | 2 | ||||||||
MIRT708652 | LYRM7 | LYR motif containing 7 | 2 | 2 | ||||||||
MIRT710520 | NDUFV3 | NADH:ubiquinone oxidoreductase subunit V3 | 2 | 2 | ||||||||
MIRT714283 | KIF1C | kinesin family member 1C | 2 | 2 | ||||||||
MIRT720438 | C19orf47 | chromosome 19 open reading frame 47 | 2 | 2 | ||||||||
MIRT720612 | ZCCHC8 | zinc finger CCHC-type containing 8 | 2 | 2 | ||||||||
MIRT722756 | SIRPB2 | signal regulatory protein beta 2 | 2 | 2 | ||||||||
MIRT723296 | MOGAT1 | monoacylglycerol O-acyltransferase 1 | 2 | 2 | ||||||||
MIRT724380 | NEK8 | NIMA related kinase 8 | 2 | 2 | ||||||||
MIRT725105 | THRA | thyroid hormone receptor, alpha | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|